Patients, pathogens, and protective immunity: The relevance of virus-induced alloreactivity in transplantation

Journal of Immunology

Volumn 176, Issue 5, 2006, Pages 2691-2696

  Koehn, Brent ^a   Gangappa, Shivaprakash ^a   Miller, Joeseph D ^b   Ahmed, Rafi ^b   Larsen, Christian P ^a  

^a EMORY UNIVERSITY   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN; T LYMPHOCYTE RECEPTOR;

ALLOIMMUNITY; ANTIGEN EXPRESSION; ANTIGEN RECOGNITION; CELL FUNCTION; CELLULAR IMMUNITY; CROSS REACTION; CYTOMEGALOVIRUS; DENDRITIC CELL; GRAFT REJECTION; HOST PATHOGEN INTERACTION; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; INNATE IMMUNITY; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; LYMPHOCYTOPENIA; MEMORY CELL; MEMORY T LYMPHOCYTE; NONHUMAN; ORGAN TRANSPLANTATION; POLYOMA VIRUS; PRIORITY JOURNAL; SHORT SURVEY; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; UPREGULATION; VIRUS INFECTION;

EID: 33644517535     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.176.5.2691     Document Type: Short Survey

References (67)

1. Maresic, D., P. V. Lehmann, and P. S. Heeger. 1998. High-resolution characterization of cytokine-producing alloreactivity in naive and allograft-primed mice. Transplantation 65: 906-914.
2. Lindahl, K. F., and D. B. Wilson. 1977. Histocompatibility antigen-activated cytotoxic T lymphocytes. II. Estimates of the frequency and specificity of precursors. J. Exp. Med. 145: 508-522.
3. Suchin, E. J., P. B. Langmuir, E. Palmer, M. H. Sayegh, A. D. Wells, and L. A. Turka. 2001. Quantifying the frequency of alloreactive T cells in vivo: new answers to an old question. J. Immunol. 166: 973-981.
4. Ashweli, J. D., C. Chen, and R. H. Schwartz. 1986. High frequency and nonrandom distribution of alloreactivity in T cell clones selected for recognition of foreign antigen in association with self class II molecules. J. Immunol. 136: 389-395.
5. Williams, M. A., J. T. Tan, A. B. Adams, M. M. Durham, N. Shirasugi, J. K. Whitmire, L. E. Harrington, R. Ahmed, T. C. Pearson, and C. P. Larsen. 2001. Characterization of virus-mediated inhibition of mixed chimerism and allospecific tolerance. J. Immunol. 167: 4987-4995.
6. Welsh, R. M., T. G. Markees, B. A. Woda, K. A. Daniels, M. A. Brehm, J. P. Mordes, D. L. Greiner, and A. A. Rossini. 2000. Virus-induced abrogation of transplantation tolerance induced by donor-specific transfusion and anti-CD 154 antibody. J. Virol. 74: 2210-2218.
7. Adams, A. B., M. A. Williams, T. R. Jones, N. Shirasugi, M. M. Durham, S. M. Kaech, E. J. Wherty, T. Onami, J. G. Lanier, K. E. Kokko, et al. 2003. Heterologous immunity provides a potent barrier to transplantation tolerance. J. Clin. Invest. 111: 1887-1895.
8. Williams, M. A., T. M. Onami, A. B. Adams, M. M. Durham, T. C. Pearson, R. Ahmed, and C. P. Larsen. 2002. Cutting edge: persistent viral infection prevents tolerance induction and escapes immune control following CD28/CD40 blockade-based regimen. J. Immunol. 169: 5387-5391.
9. Pantenburg, B., F. Heinzel, L. Das, P. S. Heeger, and A. Valujskikh. 2002. T cells primed by Leishmania major infection cross-react with alloantigens and alter the course of allograft rejection. J. Immunol. 169: 3686-3693.
10. Nikolich-Zugich, J., M. K. Slifka, and I. Messaoudi. 2004. The many important facets of T cell repertoire diversity. Nat. Rev. Immunol. 4: 123-132.
11. Goldrath, A. W., and M. J. Bevan. 1999. Selecting and maintaining a diverse T cell repertoire. Nature 402: 255-262.
12. Blanden, R. V., P. D. Hodgkih, A. Hill, V. G. Sinickas, and A. Mullbacher. 1987. Quantitative considerations of T cell activation and self tolerance. Immunol Rev. 98: 75-93.
13. Mason, D. 1998. A very high level of crossreactivity is an essential feature of the T cell receptor. Immunol. Today 19: 395-404.
14. Lanzavecchia, A., and F. Sallusto. 2000. Dynamics of T lymphocyte responses: intermediates, effectors, and memory cells. Science 290: 92-97.
15. + T cells. Curr. Opin. Immunol. 15: 336-342.
16. Lefrancois, L., and D. Masopust. 2002. T cell immunity in lymphoid and non-lymphoid tissues. Curr. Opin. Immunol. 14: 503-508.
17. Blattman, J. N., R. Antia, D. J. Sourdive, X. Wang, S. M. Kaech, K. Murali-Krishna, J. D. Altman, and R. Ahmed. 2002. Estimating the precursor frequency of naive antigen-specific CD8 T. cells. J. Exp. Med. 195: 657-664.
18. Hornick, P. I., P. A. Brookes, P. D. Mason, K. M. Taylor, M. H. Yacoub, M. L. Rose, R. Batchelor, and R. I. Lechler. 1997. Optimizing a limiting dilution culture system for quantifying the frequency of interleukin-2-producing alloreactive T helper lymphocytes. Transplantation 64: 472-479.
19. Brehm, M. A., A. K. Pinto, K. A. Daniels, J. P. Schneck, R. M. Welsh, and L. K. Selin. 2002. T cell immunodominance and maintenance of memory regulated by unexpectedly cross-reactive pathogens. Nat. Immunol. 3: 627-634.
20. Selin, L K., S. M. Varga, I. C. Wong, and R. M. Welsh. 1998. Protective heterologous antivital immunity and enhanced immunopathogenesis mediated by memory T cell populations. J. Exp. Med. 188: 1705-1715.
21. Chen, H. D., A. E. Fraire, I. Joris, M. A. Brehm, R. M. Welsh, and L. K. Selin. 2001. Memory CD8+ T cells in heterologous antiviral immunity and immunopathology in the lung. Nat. Immunol. 2: 1067-1076.
22. Kim, S. K., M. Cornberg, X. Z. Wang, H. D. Chen, L. K. Selin, and R. M. Welsh. 2005. Private specificities of CD8 T cell responses control patterns of heterologous immunity. J. Exp. Med. 201: 523-533.
23. Brehm, M. A., L. K. Selin, and R. M. Welsh. 2004. CD8 T cell responses to vital infections in sequence. Cell. Microbiol. 6: 411-421.
24. Daniel, C., S. Horvath, and P. M. Allen. 1998. A basis for alloreactivity: MHC helical residues broaden peptide recognition by the TCR. Immunity 8: 543-552.
25. d peptide complexes. Immunity 8: 553-562.
26. Kersh, G. J., and P. M. Allen. 1996. Essential flexibility in the T cell recognition of antigen. Nature 380: 495-498.
27. Hemmer, B., M. Vergelli, B. Gran, N. Ling, P. Conlon, C. Pinilla, R. Houghten, H. F. McFarland, and R. Martin. 1998. Predictable TCR antigen recognition based on peptide scans leads to the identification of agonist ligands with no sequence homology. J. Immunol. 160: 3631-3636.
28. Wedemeyer, H., E. Mizukoshi, A. R. Davis, J. R. Bennink, and B. Rehetmann. 2001. Cross-reactivity between hepatitis C virus and influenza A virus determinant-specific cytotoxic T cells. J. Virol. 75: 11392-11400.
29. + T cells from patients with cervical cancer are cross-reactive with the coronavirus NS2 protein. J. Virol. 77: 5464-5474.
30. Mongkolsapaya, J., W. Dejnirattisai, X. N. Xu, S. Vasanawathana, N. Tangthawornchaikul, A. Chairunsri, S. Sawasdivorn, T. Duangchinda, T. Dong, S. Rowland-Jones, et al. 2003. Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever. Nat. Med. 9: 921-927.
31. Welsh, R. M., L. K. Selin, and E. Szomolanyi-Tsuda. 2004. Immunological memory to viral infections. Annu. Rev. Immunol. 22: 711-743.
32. Finberg, R., S. J. Burakoff, H. Cantor, and B. Benacerraf. 1978. Biological significance of alloreactivity: T cells stimulated by Sendai virus-coated syngeneic cells specifically lyse allogeneic target cells. Proc. Natl. Acad. Sci. USA 75: 5145-5149.
33. Yang, H., and R. M. Welsh. 1986. Induction of alloreactive cytotoxic T cells by acute virus infection of mice. J. Immunol. 136: 1186-1193.
34. Nahill, S. R., and R. M. Welsh. 1993. High frequency of cross-reactive cytotoxic T lymphocytes elicited during the virus-induced polyclonal cytotoxic T lymphocyte response. J. Exp. Med. 177: 317-327.
35. Brehm, M. A., T. G. Markees, K. A. Daniels, D. L. Greiner, A. A. Rossini, and R. M. Welsh. 2003. Direct visualization of cross-reactive effector and memory allo-specific CD8 T cells generated in response to viral infections. J. Immunol. 170: 4077-4086.
36. + T cells is CD154 blockade resistant: therapeutic implications for sensitized transplant recipients. J. Immunol. 169: 4667-4673.
37. Valujskikh, A., B. Pamenburg, and P. S. Heeger. 2002. Primed allospecific T cells prevent the effects of costimulatory blockade on prolonged cardiac allograft survival in mice Am. J. Transplant. 2: 501-509.
38. Propper, D. J., J. Woo, A. M. Madeod, G. R. Catto, and A. W. Thomson. 1992. The effects of rapamycin on humoral immunity in vivo: suppression of primary responses but not of ongoing alloantibody synthesis or memory responses. Transplantation 54: 1058-1063.
39. Maxwell, J. R., R. J. Rossi, S. J. McSorley, and A. T. Vella. 2004. T cell clonal conditioning: a phase occurring early after antigen presentation but before clonal expansion is impacted by Toll-like receptor stimulation. J. Immunol. 172: 248-259.
40. Pasare, C., and R. Medzhitov. 2004. Toll-dependent control mechanisms of CD4 T cell activation. Immunity 21: 733-741.
41. + T cells undergo peripheral tolerance. Immunity 17: 73-81.
42. Ahmadzadeh, M., and D. L. Farber. 2002. Functional plasticity of an antigen-specific memory CD4 T cell population. Proc. Natl. Acad. Sci. USA 99: 11802-11807.
43. + T cell responses. J. Exp. Med. 196: 1585-1592.
44. Lombardi, G., S. Sidhu, M. Daly, J. R. Batchelor, W. Makgoba, and R. I. Lechler. 1990. Are primary alloresponses truly primary? Int. Immunol. 2: 9-13.
45. Burrows, S. R., S. L. Silins, R. Khanna, J. M. Burrows, M. Rischmueller, J. McCluskey, and D. J. Moss. 1997. Cross-reactive memory T cells for Epstein-Barr virus augment the alloresponse to common human leukocyte antigens: degenerate recognition of major histocompatibility complex-bound peptide by T cells and its role in alloreactivity. Eur. J. Immunol. 27: 1726-1736.
46. Burrows, S. R., S. L. Silins, D. J. Moss, R. Khanna, I. S. Misko, and V. P. Argaet. 1995. T cell receptor repertoire for a viral epitope in humans is diversified by tolerance to a background major histocompatibility complex antigen. J. Exp. Med. 182: 1703-1715.
47. Burrows, S. R., R. Khanna, J. M. Burrows, and D. J. Moss. 1994. An alloresponse in humans is dominated by cytotoxic T lymphocytes (CTL) cross-reactive with a single Epstein-Barr virus CTL epitope: implications for graft-versus-host disease. J. Exp. Med. 179: 1155-1161.
48. Maruya, E., S. Takemoto, and P. I. Terasaki. 1993. HLA matching: identification of permissible HLA mismatches. Clin. Transpl. 511-520.
49. Ely, L K., K. J. Green, T. Beddoe, C. S. Clements, J. J. Miles, S. P. Bottomley, D. Zetnich, L. Kjer-Nielsen, A. W. Purcell, J. McCluskey, et al. 2005. Antagonism of antivital and allogeneic activity of a human public CTL clonotype by a single altered peptide ligand: implications for allograft rejection. J. Immunol. 174: 5593-5601.
50. Burrows, S. R., R. Khanna, and D. J. Moss. 1999. Direct alloreactivity by human cytotoxic T lymphocytes can Be inhibited by altered peptide ligand antagonism. Blood 93: 1020-1024.
51. Heeger, P. S., N. S. Greenspan, S. Kuhlenschmidt, C. Dejelo, D. E. Hricik, J. A. Schulak, and M. Tary-Lehmann. 1999. Pretransplant frequency of donor-specific, IFN-γ-producing lymphocytes is a manifestation of immunologic memory and correlates with the risk of posttransplant rejection episodes. J. Immunol. 163: 2267-2275.
52. Iwasaki, A., and R. Medzhitov. 2004. Toll-like receptor control of the adaptive immune responses. Nat. Immunol. 5: 987-995.
53. Jung, S., and D. R. Littman. 1999. Chemokine receptors in lymphoid organ homeostasis. Curr. Opin. Immunol. 11: 319-325.
54. Ostler, T., H. Pircher, and S. Ehl. 2003. "Bystander" recruitment of systemic memory T cells delays the immune response to respiratory virus infection. Eur. J. Immunol. 33: 1839-1848.
55. + T cells to the lung during influenza pneumonia. J. Immunol. 167: 6983-6990.
56. Chen, A. M., N. Khanna, S. A. Stohlman, and C. C. Bergmann. 2005. Virus-specific and bystander CD8 T cells recruited during virus-induced encephalomyelitis. J. Virol. 79: 4700-4708.
57. Schulz, O., S. S. Diebold, M. Chen, T. I. Naslund, M. A. Nolte, L. Alexopoulou, Y. T. Azuma, R. A. Flavell, P. Liljestrom, and C. Reis e Sousa. 2005. Toll-like receptor 3 promotes cross-priming to virus-infected cells. Nature 433: 887-892.
58. + T cell populations lacking helper function. Nat. Immunol. 6: 163-170.
59. Lang, K. S., M. Recher, T. Junt, A. A. Navarini, N. L. Harris, S. Freigang, B. Odermatt, C. Conrad, L. M. Ittner, S. Bauer, et al. 2005. Toll-like receptor engagement converts T cell autoreactivity into overt autoimmune disease. Nat. Med. 11: 138-145.
60. Goldstein, D. R., B. M. Tesar, S. Akita, and F. G. Lakkis. 2003. Critical role of the Toll-like receptor signal adaptor protein MyD88 in acute allograft rejection. J. Clin. Invest. 111: 1571-1578.
61. Brehm, M. A., K. A. Daniels, J. R. Orraldo, and R. M. Welsh. 2005. Rapid conversion of effector mechanisms from NK to T cells during virus-induced lysis of allogeneic implants in vivo. J. Immunol. 174: 6663-6671.
62. Cousens, L. P., J. S. Orange, and C. A. Biron. 1995. Endogenous IL-2 contributes to T cell expansion and IFN-γ production during lymphocytic choriomeningitis virus infection. J. Immunol. 155: 5690-5699.
63. Tough, D. F., P. Borrow, and J. Sprent. 1996. Induction of bystander T cell proliferation by viruses and type 1 Interferon in vivo. Science 272: 1947-1950.
64. Murali-Krishna, K., and R. Ahmed. 2000. Cutting edge: naive T cells masquerading as memory cells. J. Immunol. 165: 1733-1737.
65. Starzl, T. E., N. Mutase, K. Abu-Elmagd, E. A. Gray, R. Shapiro, B. Eghtesad, R. J. Corry, M. L. Jordan, P. Fontes, T. Gayowski, et al. 2003. Tolerogenic immunosuppression for organ transplantation. Lancet 361: 1502-1510.
66. Wu, Z., S. J. Bensinger, J. Zhang, C. Chen, X. Yuan, X. Huang, J. F. Markmann, A. Kassaee, B. R. Rosengard, W. W. Hancock, et al. 2004. Homeostatic proliferation is a barrier to transplantation tolerance. Nat. Med. 10: 87-92.
67. Pearl, J. P., J. Parris, D. A. Hale, S. C. Hoffmann, W. B. Bernstein, K. L. McCoy, S. J. Swanson, R. B. Mannon, M. Roederer, and A. D. Kirk. 2005. Immunocompetent T cells with a memory-like phenotype are the dominant cell type following antibody-mediated T cell depletion. Am. J. Transplant. 5: 465-474.